These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Leprosy and AIDS: a review of the literature and speculations on the impact of CD4+ lymphocyte depletion on immunity to Mycobacterium leprae. Miller RA Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):639-44. PubMed ID: 1687045 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil NETworking in ENL: Potential as a Putative Biomarker: Future Insights. Sahu S; Sharma K; Sharma M; Narang T; Dogra S; Minz RW; Chhabra S Front Med (Lausanne); 2021; 8():697804. PubMed ID: 34336901 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in the Diagnosis of Erythema Nodosum Leprosum: A Retrospective Study. Tanojo N; Damayanti ; Utomo B; Ervianti E; Murtiastutik D; Prakoeswa CRS; Listiawan MY Trop Med Infect Dis; 2022 Mar; 7(3):. PubMed ID: 35324586 [TBL] [Abstract][Full Text] [Related]
9. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631 [TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker. Vilani-Moreno FR; Brito-de-Souza VN; Silva SMUR; Barbosa ASAA; Sartori BGC; Campanelli AP; Barreto JA; Virmond MDCL Indian J Dermatol Venereol Leprol; 2021; 87(2):190-198. PubMed ID: 33769734 [TBL] [Abstract][Full Text] [Related]
11. Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19. de Oliveira JADP; de Athaide MM; Rahman AU; de Mattos Barbosa MG; Jardim MM; Moraes MO; Pinheiro RO Front Cell Infect Microbiol; 2022; 12():815738. PubMed ID: 35281455 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination and leprosy-A UK hospital-based retrospective cohort study. de Barros B; Pierce R; Sprenger C; Ong ELH; Walker SL PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011493. PubMed ID: 37540711 [TBL] [Abstract][Full Text] [Related]
15. Case Report: Glans penile necrosis in a patient with SARS-CoV-2 and leprosy infection. Ismy J; Khalilullah SA; Bahagianto AF F1000Res; 2022; 11():142. PubMed ID: 39233873 [TBL] [Abstract][Full Text] [Related]
16. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients. Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538 [TBL] [Abstract][Full Text] [Related]
18. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin. Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186 [TBL] [Abstract][Full Text] [Related]
19. Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19. Zahorec R; Hulin I; Zahorec P Bratisl Lek Listy; 2020; 121(7):466-470. PubMed ID: 32989997 [TBL] [Abstract][Full Text] [Related]
20. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy. Rao TD; Rao PR Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]